HC Wainwright & Co. reiterated coverage on Inventiva with a new price target

9/22/21 6:24:39 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Inventiva with a rating of Buy and set a new price target of $40.00 from $38.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IVA

Date	Price Target	Rating	Analyst
2/21/2025	$10.00	Buy	TD Cowen
11/12/2024	$3.00	Neutral	UBS
10/27/2023	$12.00	Buy	Canaccord Genuity
5/31/2023	$11.00	Buy	ROTH MKM
5/19/2023		Sell → Buy	Societe Generale
3/17/2023	$27.00	Buy	Stifel
11/15/2022		Buy → Sell	Societe Generale
11/22/2021	$40.00 → $42.00	Buy	HC Wainwright & Co.